POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy
POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.
Thomas Bodetti
Interesting study, however it should be noted that excluding non MSM patients from the study does not provide a good basis of comparing MSM as a modality, meaning that regardless of classification the patients who are not MSM can develop the same modalities. The end result is incomplete as a basis for information it is interesting but not much beyond that.
October 18, 2013 • USA